Ankylosing spondylitis diagnosis in US patients with back pain: identifying providers involved and factors associated with rheumatology referral delay
Authors:
Open Access
- 18 March 2016
- journal article
- research article
- Published by Springer Nature in Clinical Rheumatology
- Vol. 35 (7) , 1769-1776
Abstract
This study aimed to identify providers involved in diagnosing ankylosing spondylitis (AS) following back pain diagnosis in the USA and to identify factors leading to the delay in rheumatology referrals. The Truven Health MarketScan® US Commercial Database was searched for patients aged 18–64 years with back pain diagnosis in a non-rheumatology setting followed by AS diagnosis in any setting during January 2000–December 2012. Patients with a rheumatologist visit on or before AS diagnosis were considered referred. Cox regression was used to determine factors associated with referral time after adjusting for age, sex, comorbidities, physician specialty, drug therapy, and imaging procedures. Of 3336 patients included, 1244 (37 %) were referred to and diagnosed by rheumatologists; the others were diagnosed in primary care (25.7 %), chiropractic/physical therapy (7 %), orthopedic surgery (3.8 %), pain clinic (3.6 %), acute care (3.4 %), and other (19.2 %) settings. Median time from back pain diagnosis to rheumatology referral was 307 days and from first rheumatologist visit to AS diagnosis was 28 days. Referred patients were more likely to be younger (hazard ratio [HR] = 0.986; p < 0.0001), male (HR = 1.15; p = 0.0163), diagnosed with uveitis (HR = 1.49; p = 0.0050), referred by primary care physicians (HR = 1.96; p < 0.0001), prescribed non-steroidal anti-inflammatory drugs (HR = 1.55; p < 0.0001), disease-modifying antirheumatic drugs (HR = 1.33; p < 0.0001), and tumor necrosis factor inhibitors (HR = 1.40; p = 0.0036), and to have had spinal/pelvic X-ray prior to referral (HR = 1.28; p = 0.0003). During 2000–2012, most patients with AS were diagnosed outside of rheumatology practices. The delay before referral to rheumatology was 10 months; AS diagnosis generally followed within a month. Earlier referral of patients with AS signs and symptoms may lead to more timely diagnosis and appropriate treatment.Keywords
Funding Information
- AbbVie
This publication has 25 references indexed in Scilit:
- First update of the current evidence for the management of ankylosing spondylitis with non-pharmacological treatment and non-biologic drugs: a systematic literature review for the ASAS/EULAR management recommendations in ankylosing spondylitisRheumatology, 2012
- Referral strategies for early diagnosis of axial spondyloarthritisNature Reviews Rheumatology, 2012
- 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitisAnnals of the Rheumatic Diseases, 2011
- Services for people with ankylosing spondylitis in the UK—a survey of rheumatologists and patientsRheumatology, 2011
- Race, Care Seeking, and Utilization for Chronic Back and Neck Pain: Population PerspectivesThe Journal of Pain, 2010
- The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritisAnnals of the Rheumatic Diseases, 2009
- Diagnosis delay in patients with ankylosing spondylitis: factors and outcomes—an Indian perspectiveClinical Rheumatology, 2008
- Disease pattern of spondyloarthropathies in Spain: description of the first national registry (REGISPONSER) extended reportRheumatology, 2007
- Early referral recommendations for ankylosing spondylitis (including pre-radiographic and radiographic forms) in primary careAnnals of the Rheumatic Diseases, 2005
- Use of the International Classification of Diseases (ICD-9-CM) to Identify Hospitalizations for Mechanical Low Back Problems in Administrative DatabasesSpine, 1992